ArticleCureus2026
Preliminary Clinical Experience in the Treatment of Recalcitrant Plantar Heel Pain With Stromal Vascular Fraction: Short- and Long-Term Findings From a Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case series aims to report preliminary clinical experience in treating plantar heel pain with stromal vascular fraction (SVF) derived from adipose tissue. Four representative cases are presented. The patients were treated with a single injection of stromal vascular fraction obtained through mechanical processing of each patient's adipose tissue. Each patient was followed up for up to 360 days after treatment. Pain was evaluated with the visual analog scale (VAS), and ultrasound (US) examination was performed at baseline and six months after treatment. A significant improvement in the VAS scale was observed in all patients within seven days. This improvement was maintained for up to 360 days. This is the first report on the treatment of plantar heel pain with SVF. These initial cases showed promising results in terms of fast and durable pain resolution. A larger clinical series is currently underway to confirm these preliminary data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.